株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドのワクチン市場の分析と予測

Indian Vaccine Market Report and Forecast 2018-2023

発行 IMARC Services Pvt. Ltd. 商品コード 345917
出版日 ページ情報 英文 75 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.58円で換算しております。
Back to Top
インドのワクチン市場の分析と予測 Indian Vaccine Market Report and Forecast 2018-2023
出版日: 2018年02月04日 ページ情報: 英文 75 Pages
概要

当レポートでは、インドのワクチン市場について調査分析し、ワクチンの概要と疫学、市場動向 (現在・過去) 、セグメント別の市場分析、市場の見通しなど、体系的な情報を提供しています。

第1章 調査手法と市場定義

第2章 エグゼクティブサマリー

第3章 インドのワクチン市場

  • イントロダクションと歴史
  • 市場動向 (現在・過去)
  • 市場内訳:セグメント別
  • 市場内訳:主要企業別
  • 市場促進要因と課題
  • 市場の見通し

第4章 単味ワクチンと混合ワクチンの市場分析

  • BCG
  • HIB
  • インフルエンザ
  • 水痘
  • 腸チフス
  • 日本脳炎
  • 麻疹
  • 破傷風トキソイド
  • A型肝炎
  • 風疹
  • DPT
  • ポリオ
  • MMR
  • ロタウイルス
  • B型肝炎
  • 肺炎球菌
  • 髄膜炎菌
  • 狂犬病
  • HPV

第5章 規制の枠組み

図表

目次
Product Code: SR1018B43_Report

Over the years, India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines across the globe. Currently, more than two thirds of the total volume of the vaccines manufactured is exported while the rest is utilised domestically. According to a new report by IMARC titled "Indian Vaccine Market Report and Forecast 2018-2023", the Indian vaccine market reached a value of around INR 69 Billion in 2017, growing at a CAGR of around 18% during 2010-2017.

The strong growth of the market can be attributed to numerous favourable factors. One of the primary forces that is stimulating the market growth is the increasing investments in research and development (R&D) by government funding agencies like the Department of Biotechnology, the Indian Council of Medical Research, and the Ministry of Health and Family Welfare. The launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases in the country, has also significantly added to the market growth. Moreover, with advancement in technology, the vaccine production capacity along with cold chain storage facilities have also been improved. Besides this, the advent of a number of privately owned firms in India have positively transformed the industry. These firms have been making efforts to bring low cost solutions and are increasingly shifting their focus on innovation so as to increase their revenues. Owing to these factors, India has emerged as a global vaccine manufacturing hub.

The report has segmented the Indian vaccine market on the basis of vaccine type. In 2017, varicella accounted for the maximum share of the total monovalent vaccine market in India whereas oral polio accounted for the biggest share of the combined vaccine market in India.The report has also analysed the competitive landscape and provides the profiles of the key players operating in the market. In 2017, GlaxoSmithKline represented the largest player in the Indian vaccine market. Other major players included Sanofi Aventis, Pfizer, Novartis and Serum Institute of India.

This report provides a deep insight into the Indian vaccine industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, pricing analysis, etc. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine industry in any form.

Key Vaccines Covered in the Report

BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent and Dengue

Focus of the Analysis for Each Vaccine:

  • Vaccine Overview
  • Historical and Current Market Trends
  • Market Breakup by Prescriber
  • Market Breakup by Public and Private Sector
  • Market Outlook

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Indian Vaccine Industry

  • 5.1. Market Overview
  • 5.2. Market Performance
    • 5.2.1. Volume Trends
    • 5.2.2. Value Trends
  • 5.3. Market Breakup by Segment
  • 5.4. Market Forecast
    • 5.4.1. Volume Trends
    • 5.4.2. Value Trends

6. Market Analysis of Various Monovalent and Combined Vaccines

  • 6.1. BCG Vaccine Market
    • 6.1.1. Vaccine Overview
    • 6.1.2. Market Performance
    • 6.1.3. Market Breakup by Prescriber
    • 6.1.4. Market Breakup by Public and Private Sector
    • 6.1.5. Market Forecast
  • 6.2. HIB Vaccine Market
    • 6.2.1. Vaccine Overview
    • 6.2.2. Market Performance
    • 6.2.3. Market Breakup by Prescriber
    • 6.2.4. Market Breakup by Public and Private Sector
    • 6.2.5. Market Forecast
  • 6.3. Influenza Vaccine Market
    • 6.3.1. Vaccine Overview
    • 6.3.2. Market Performance
    • 6.3.3. Market Breakup by Prescriber
    • 6.3.4. Market Breakup by Public and Private Sector
    • 6.3.5. Market Forecast
  • 6.4. Varicella Vaccine Market
    • 6.4.1. Vaccine Overview
    • 6.4.2. Market Performance
    • 6.4.3. Market Breakup by Prescriber
    • 6.4.4. Market Breakup by Public and Private Sector
    • 6.4.5. Market Forecast
  • 6.5. Typhoid Vaccine Market
    • 6.5.1. Vaccine Overview
    • 6.5.2. Market Performance
    • 6.5.3. Market Breakup by Prescriber
    • 6.5.4. Market Breakup by Public and Private Sector
    • 6.5.5. Market Forecast
  • 6.6. Japanese Encephalitis Vaccine Market
    • 6.6.1. Vaccine Overview
    • 6.6.2. Market Performance
    • 6.6.3. Market Breakup by Prescriber
    • 6.6.4. Market Breakup by Public and Private Sector
    • 6.6.5. Market Forecast
  • 6.7. Measles Vaccine Market
    • 6.7.1. Vaccine Overview
    • 6.7.2. Market Performance
    • 6.7.3. Market Breakup by Prescriber
    • 6.7.4. Market Breakup by Public and Private Sector
    • 6.7.5. Market Forecast
  • 6.8. Tetanus Toxoid Vaccine Market
    • 6.8.1. Vaccine Overview
    • 6.8.2. Market Performance
    • 6.8.3. Market Breakup by Prescriber
    • 6.8.4. Market Breakup by Public and Private Sector
    • 6.8.5. Market Forecast
  • 6.9. Hepatitis A Vaccine Market
    • 6.9.1. Vaccine Overview
    • 6.9.2. Market Performance
    • 6.9.3. Market Breakup by Prescriber
    • 6.9.4. Market Breakup by Public and Private Sector
    • 6.9.5. Market Forecast
  • 6.10. Rubella Vaccine Market
    • 6.10.1. Vaccine Overview
    • 6.10.2. Market Performance
    • 6.10.3. Market Breakup by Prescriber
    • 6.10.4. Market Breakup by Public and Private Sector
    • 6.10.5. Market Forecast
  • 6.11. DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market
    • 6.11.1. Vaccine Overview
    • 6.11.2. Market Performance
    • 6.11.3. Market Breakup by Prescriber
    • 6.11.4. Market Breakup by Public and Private Sector
    • 6.11.5. Market Forecast
  • 6.12. OPV (Oral Polio Vaccine) Vaccine Market
    • 6.12.1. Vaccine Overview
    • 6.12.2. Market Performance
    • 6.12.3. Market Breakup by Prescriber
    • 6.12.4. Market Breakup by Public and Private Sector
    • 6.12.5. Market Forecast
  • 6.13. MMR Vaccine Market
    • 6.13.1. Vaccine Overview
    • 6.13.2. Market Performance
    • 6.13.3. Market Breakup by Prescriber
    • 6.13.4. Market Breakup by Public and Private Sector
    • 6.13.5. Market Forecast
  • 6.14. Rotavirus Vaccine Market
    • 6.14.1. Vaccine Overview
    • 6.14.2. Market Performance
    • 6.14.3. Market Breakup by Prescriber
    • 6.14.4. Market Breakup by Public and Private Sector
    • 6.14.5. Market Forecast
  • 6.15. Hepatitis B Vaccine Market
    • 6.15.1. Vaccine Overview
    • 6.15.2. Market Performance
    • 6.15.3. Market Breakup by Prescriber
    • 6.15.4. Market Breakup by Public and Private Sector
    • 6.15.5. Market Forecast
  • 6.16. Pneumococcal Vaccine Market
    • 6.16.1. Vaccine Overview
    • 6.16.2. Market Performance
    • 6.16.3. Market Breakup by Prescriber
    • 6.16.4. Market Breakup by Public and Private Sector
    • 6.16.5. Market Forecast
  • 6.17. Meningococcal Vaccine Market
    • 6.17.1. Vaccine Overview
    • 6.17.2. Market Performance
    • 6.17.3. Market Breakup by Prescriber
    • 6.17.4. Market Breakup by Public and Private Sector
    • 6.17.5. Market Forecast
  • 6.18. Rabies Vaccine Market
    • 6.18.1. Vaccine Overview
    • 6.18.2. Market Performance
    • 6.18.3. Market Breakup by Prescriber
    • 6.18.4. Market Breakup by Public and Private Sector
    • 6.18.5. Market Forecast
  • 6.19. HPV Vaccine Market
    • 6.19.1. Vaccine Overview
    • 6.19.2. Market Performance
    • 6.19.3. Market Breakup by Prescriber
    • 6.19.4. Market Breakup by Public and Private Sector
    • 6.19.5. Market Forecast
  • 6.20. Hexavalent Vaccines
  • 6.21. Dengue Vaccines

7. SWOT Analysis

  • 7.1. Strengths
  • 7.2. Weaknesses
  • 7.3. Opportunities
  • 7.4. Threats

8. Value Chain Analysis

  • 8.1. Exploratory Stage
  • 8.2. Preclinical and Clinical Development
  • 8.3. Regulatory Approval
  • 8.4. Manufacturing
  • 8.5. Marketing and Distribution

9. Porter's Five Forces Analysis

  • 9.1. Overview
  • 9.2. Bargaining Power of Supplier
  • 9.3. Bargaining Power of Buyers
  • 9.4. Degree of Competition
  • 9.5. Threat of New Entrants
  • 9.6. Threat of Substitutes

10. Competitive Landscape

  • 10.1. Competitive Structure
  • 10.2. Market by Key Players

11. Pricing Analysis

12. Regulatory Framework

13. Key Players Profiles

  • 13.1. GlaxoSmithKline
  • 13.2. Sanofi Aventis
  • 13.3. Serum Institute of India
  • 13.4. Panacea Biotec
  • 13.5. Pfizer
  • 13.6. Novartis
  • 13.7. VHB Lifesciences
  • 13.8. Zydus Cadila
  • 13.9. MSD
  • 13.10. Shantha Biotech

List of Figures

  • Figure 1: Indian Vaccine Market: Vaccine Development and Introduction
  • Figure 2: Indian Vaccine Market: Major Drivers and Challenges
  • Figure 3: India: Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 4: India: Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 5: India: Monovalent Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
  • Figure 6: India: Combined Vaccine Market: Value Breakup by Vaccine Type (in %), 2017
  • Figure 7: India: Vaccine Market Forecast: Doses Administered (in Million), 2018 - 2023
  • Figure 8: India: Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 9: India: BCG Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 10: India: BCG Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 11: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 12: India: BCG Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 13: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 14: India: HIB Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 15: India: HIB Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 16: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 17: India: HIB Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 18: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 19: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 20: India: Influenza Vaccine Market: Sales Value (in Million INR),
  • Figure 21: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 22: India: Influenza Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 23: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 24: India: Varicella Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 25: India: Varicella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 26: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 27: India: Varicella Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 28: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 29: India: Typhoid Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 30: India: Typhoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 31: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 32: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 33: India: Typhoid Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 34: India: JE Vaccine Market: Doses Administered (in Million), 2010 -2017
  • Figure 35: India: JE Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 36: India: JE Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 37: India: JE Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 38: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 39: India: Measles Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 40: India: Measles Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 41: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 42: India: Measles Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 43: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 44: India: Tetanus Toxoid Vaccine Market: Doses Administered
  • Figure 45: India: Tetanus Toxoid Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 46: India: Tetanus Toxoid Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 47: India: Tetanus Toxoid Vaccine Market: Breakup by Sector (in %),2017
  • Figure 48: India: Tetanus Toxoid Vaccine Market: Sales Value Forecast
  • Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in '000), 2010 - 2017
  • Figure 50: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 51: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 52: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 53: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 55: India: Rubella Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 56: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 57: India: Rubella Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 58: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 59: India: DPT Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 60: India: DPT Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 61: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 62: India: DPT Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 63: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 64: India: OPV Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 65: India: OPV Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 66: India: OPV Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 67: India: OPV Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 68: India: OPV Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 69: India: MMR Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 70: India: MMR Vaccine Market: Sales Value (in Million INR), 2010 - 2017
  • Figure 71: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2017
  • Figure 72: India: MMR Vaccine Market: Breakup by Sector (in %), 2017
  • Figure 73: India: MMR Vaccine Market: Sales Value Forecast (in Million INR), 2018 - 2023
  • Figure 74: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010 - 2017
  • Figure 75: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010 - 2017

List of Tables

  • Table 1: Indian Vaccine Market: Key Industry Highlights, 2017 and 2023
  • Table 2: India: BCG Vaccine: Overview
  • Table 3: India: HIB Vaccine: Overview
  • Table 4: India: Influenza Vaccine: Overview
  • Table 5: India: Varicella Vaccine: Overview
  • Table 6: India: Typhoid Vaccine: Overview
  • Table 7: India: JE Vaccine: Overview
  • Table 8: India: Measles Vaccine: Overview
  • Table 9: India: Tetanus Toxoid Vaccine: Overview
  • Table 10: India: Hepatitis A Vaccine: Overview
  • Table 11: India: Rubella Vaccine: Overview
  • Table 12: India: DPT Vaccine: Overview
  • Table 13: India: OPV Vaccine: Overview
  • Table 14: India: MMR Vaccine: Overview
  • Table 15: India: Rotavirus Vaccine: Overview
  • Table 16: India: Hepatitis B Vaccine: Overview
  • Table 17: India: Pneumococcal Vaccine: Overview
  • Table 18: India: Meningococcal Vaccine: Overview
  • Table 19: India: Rabies Vaccine: Overview
  • Table 20: India: HPV Vaccine: Overview
  • Table 21: India: Vaccine Market: Key Components in Drug Delivery
Back to Top